Sarcopenia: recent advances for detection, progression, and metabolic alterations along with therapeutic targets
Canadian Journal of Physiology and Pharmacology · 2024
DOI: 10.1139/cjpp-2024-0201 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2024. Verfasst von Syeda Roohina Ali und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, USF Health Taneja College of Pharmacy, University of South Florida, Tampa, FL, US. Hauptthemen laut MEDLINE: Sarcopenia. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Sarcopenia, a disorder marked by muscle loss and dysfunction, is a global health concern, particularly in aging populations. Sarcopenia is intricately related to various health conditions, including obesity, dysphagia, and frailty, which underscores the complexity. Despite recent advances in metabolomics and other omics data for early detection and treatment, the precise characterization and diagnosis of sarcopenia remains challenging. In the present review we provide an overview of the complex metabolic mechanisms that underlie sarcopenia, with particular emphasis on protein, lipid, carbohydrate, and bone metabolism. The review highlights the importance of leucine and other amino acids in promoting muscle protein synthesis and clarifies the critical role played by amino acid metabolism in preserving muscular health. In addition, the review provides insights regarding lipid metabolism on sarcopenia, with an emphasis on the effects of inflammation and insulin resistance. The development of sarcopenia is largely influenced by insulin resistance, especially with regard to glucose metabolism. Overall, the review emphasizes the complex relationship between bone and muscle health by highlighting the interaction between sarcopenia and bone metabolism. Furthermore, the review outlines various therapeutic approaches and potential biomarkers for diagnosing sarcopenia. These include pharmacological strategies such as hormone replacement therapy and anabolic steroids as well as lifestyle modifications such as exercise, nutrition, and dietary changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, USF Health Taneja College of Pharmacy, University of South Florida, Tampa, FL, US.
ORCID-Profile: Srinivas M Tipparaju, Wanling Xuan
Förderung
- NIA NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
Zitieren
APA
Ali, S. R., Nkembo, A. T., Tipparaju, S. M., Ashraf, M., & Xuan, W. (2024). Sarcopenia: recent advances for detection, progression, and metabolic alterations along with therapeutic targets. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2024-0201
Vancouver
Ali SR, Nkembo AT, Tipparaju SM, Ashraf M, Xuan W. Sarcopenia: recent advances for detection, progression, and metabolic alterations along with therapeutic targets. Canadian Journal of Physiology and Pharmacology. 2024. doi:10.1139/cjpp-2024-0201
BibTeX
@article{Ali2024,
author = {Ali, Syeda Roohina and Nkembo, Augustine T and Tipparaju, Srinivas M and Ashraf, Muhammad and Xuan, Wanling},
title = {Sarcopenia: recent advances for detection, progression, and metabolic alterations along with therapeutic targets},
journal = {Canadian Journal of Physiology and Pharmacology},
year = {2024},
doi = {10.1139/cjpp-2024-0201}
}
EUVIMED